DiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Clinical Trials as TopicDouble-Blind MethodPlacebo EffectTreatment OutcomeClinical Trials, Phase III as TopicClinical Trials, Phase II as TopicResearch DesignClinical Trials, Phase I as TopicControlled Clinical Trials as TopicRandomized Controlled Trials as TopicCross-Over StudiesTime FactorsPatient SelectionSingle-Blind MethodDrug Therapy, CombinationMulticenter Studies as TopicProspective StudiesFollow-Up StudiesDrug Administration ScheduleAdministration, OralPlacebosClinical ProtocolsClinical Trials Data Monitoring CommitteesClinical Trials, Phase IV as TopicDose-Response Relationship, DrugNeoplasmsEarly Termination of Clinical TrialsAntineoplastic AgentsPilot ProjectsSeverity of Illness IndexQuality of LifeSample SizePain MeasurementEndpoint DeterminationResearch SubjectsCombined Modality TherapyRandom AllocationRecurrencePatient ComplianceUnited StatesOutcome Assessment (Health Care)Antineoplastic Combined Chemotherapy ProtocolsCost-Benefit AnalysisIntention to Treat AnalysisSurvival AnalysisEvidence-Based MedicinePhytotherapyDrug CombinationsPainRisk FactorsInfusions, IntravenousQuestionnairesAnalysis of VarianceDisease ProgressionDrug EvaluationInformed ConsentBreast NeoplasmsReproducibility of ResultsDrugs, InvestigationalTreatment FailurePrognosisDisease-Free SurvivalBiomedical ResearchData Interpretation, StatisticalBiological MarkersRisk AssessmentAdministration, TopicalSurvival RateStrokeAcute DiseaseAntibodies, MonoclonalChronic DiseaseAntibodies, Monoclonal, HumanizedFeasibility StudiesPatient DropoutsTherapeutic Human ExperimentationBlood PressureAdministration, InhalationPatient ParticipationExercise TherapyAnti-Inflammatory AgentsHIV InfectionsMeta-Analysis as TopicDrug ApprovalMedical OncologyDietary SupplementsKaplan-Meier EstimateDelayed-Action PreparationsCognitive TherapyBronchodilator AgentsUnited States Food and Drug AdministrationPatient SatisfactionStatistics, NonparametricAnti-Inflammatory Agents, Non-SteroidalAntihypertensive AgentsSafetyAdministration, CutaneousNauseaDrug IndustryHypoglycemic Agents